Sign In
Buy BHC
$4.95
-0.0600 (-1.20%)
At Close: Jun 03, 2026
Tracking John Paulson's Paulson & Company Portfolio - Q2 2020 Update
09:49am, Wednesday, 19'th Aug 2020
John Paulson’s 13F portfolio value increased from $2.62B to $3.13B this quarter. Paulson & Company's largest three positions are Bausch Health, Horizon Therapeutics, and SPDR Gold ETF.
Australia's TGA Approves BAUSCH + LOMB ULTRA® ONE DAY Silicone Hydrogel Daily Disposable Contact Lenses
11:00am, Tuesday, 18'th Aug 2020
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that it has received approval from Australia's Therapeutic Goods
Bausch + Lomb Launches Innovative Bausch + Lomb INFUSE™ Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses
11:00am, Monday, 17'th Aug 2020
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced the launch of Bausch + Lomb INFUSE™ silicone hydrogel (SiHy) da
Health Canada Approves BAUSCH + LOMB ULTRA ONE DAY® Silicone Hydrogel Daily Disposable Contact Lenses
11:00am, Tuesday, 11'th Aug 2020
Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today announced that it has received approval from Health Canada for the sale of
Analyzing Bausch Health's Unusual Options Activity
05:35pm, Friday, 07'th Aug 2020
On Friday, shares of Bausch Health Cos (NYSE: BHC) saw unusual options activity. After the option alert, the stock price moved down to $18.14. * Sentiment: BULLISH * Option Type: TRADE * Trade Type
Bausch (BHC) Q2 Earnings & Revenues Miss Estimates, Down Y/Y
02:48pm, Friday, 07'th Aug 2020
Bausch (BHC) misses on earnings and sales in the second quarter and announces plans to spin off its eye care division.
Valeant Era Nears an End With Bausch Eye Spinoff
03:03pm, Thursday, 06'th Aug 2020
(Bloomberg Opinion) -- The Valeant era may truly be nearing an end for Bausch Health Health Cos. with the planned spinoff of its eponymous Bausch+ Lomb eye-care unit, announced Thursday.Bausch, which
Bausch Health To Spin Off Eye Care Business; Shares Surge 18%
02:33pm, Thursday, 06'th Aug 2020
Shares in Bausch Health Companies spiked 18% as the Canadian drugmaker announced a plan to spin off its eye health care business, Bausch + Lomb, into an independent publicly traded entity.The stock so
Dow Jones Today, Stocks Open Lower After Jobless Data; Health Sector Rallies Behind Bristol Myers, Bausch Health
01:59pm, Thursday, 06'th Aug 2020
GoDaddy and Bausch Health jabbed higher, Pfizer helped lead the Dow Jones today, as stocks turned mixed after weekly jobless data.
Bausch Health Soars, Hilton Drops, and the Dow Is Slipping
01:57pm, Thursday, 06'th Aug 2020
U.S. stocks edged slightly lower Thursday morning as investors awaited the latest read on unemployment figures. The Labor Department is set to release its figures on initial jobless claims for the we
Bausch Health Shares Soar on Bausch & Lomb Eye-Care Spinoff Plans
01:55pm, Thursday, 06'th Aug 2020
Bausch Health said its eye-care business, which generated $4.9 billion in 2019 revenue, will be reporting as a separate division by the first quarter of next year.
Bausch Health (BHC) Q2 Earnings and Revenues Miss Estimates
01:05pm, Thursday, 06'th Aug 2020
Bausch (BHC) delivered earnings and revenue surprises of -28.79% and -8.27%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Bausch Health to spin off eye care business, shares soar
11:28am, Thursday, 06'th Aug 2020
Bausch's U.S. shares surged 28% before the opening bell. Bausch Health, previously known as Valeant Pharmaceuticals, has sought to get past a flurry of investigations into its accounting and pricing
UPDATE: Bausch Health shares soar 27% premarket after confirming to spin off eye-care business
11:12am, Thursday, 06'th Aug 2020
Bausch Health Cos. shares soared 27% in premarket trade Thursday, after the company said it is planning to spin off its eye-care business into a separate public company, confirming a Wall Street Jour
Bausch Health Announces Its Intention To Spin Off Its Eye Health Business Into An Independent Publicly Traded Company
10:59am, Thursday, 06'th Aug 2020
Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company") today announced that it intends to spin off its leading eye health business into an independent publicly traded entity (
